TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

53 hedge funds and large institutions have $20.6M invested in Theriva Biologics in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

28% less funds holding

Funds holding: 74 → 53 (-21)

78% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 27

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.91M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$629K
2
+$521K
3
+$273K
4
PP
Paloma Partners
Connecticut
+$207K
5
LP
LMR Partners
United Kingdom
+$194K

Top Sellers

1
-$2.5M
2
-$715K
3
-$532K
4
Northern Trust
Northern Trust
Illinois
-$466K
5
BCM
Bridgeway Capital Management
Texas
-$228K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$4K
52
$2K
53
$2K
54
$2K
55
$1K
56
$1K
57
$54
58
$12
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4